<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/43ECF77B-CD97-49C9-812D-40CB69D1D03B"><gtr:id>43ECF77B-CD97-49C9-812D-40CB69D1D03B</gtr:id><gtr:name>San Raffaele Hospital</gtr:name><gtr:address><gtr:line1>29 Via Prinetti</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/43ECF77B-CD97-49C9-812D-40CB69D1D03B"><gtr:id>43ECF77B-CD97-49C9-812D-40CB69D1D03B</gtr:id><gtr:name>San Raffaele Hospital</gtr:name><gtr:address><gtr:line1>29 Via Prinetti</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/91EBD812-9521-4715-ACEE-D051FB5A0C2B"><gtr:id>91EBD812-9521-4715-ACEE-D051FB5A0C2B</gtr:id><gtr:firstName>Alexandra</gtr:firstName><gtr:surname>Rowe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8C107475-670B-4B8A-A725-6FA0A2874084"><gtr:id>8C107475-670B-4B8A-A725-6FA0A2874084</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Skidmore</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9D31B22D-CA64-4E36-B3CB-3DDC0B025901"><gtr:id>9D31B22D-CA64-4E36-B3CB-3DDC0B025901</gtr:id><gtr:firstName>Edwin</gtr:firstName><gtr:otherNames>Alexander</gtr:otherNames><gtr:surname>Yates</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C33FE08B-D543-444C-B273-679DAA53C2E5"><gtr:id>C33FE08B-D543-444C-B273-679DAA53C2E5</gtr:id><gtr:firstName>Scott</gtr:firstName><gtr:surname>Guimond</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700852"><gtr:id>D3A117C6-38C1-4ABA-9774-BCF7CBBCD1E6</gtr:id><gtr:title>Novel semi-synthetic carbohydrates as potential therapeutics for severe malaria</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700852</gtr:grantReference><gtr:abstractText>Severe malaria is a disease that kills millions every year, especially in developing nations, resulting in widespread suffering and economic damage. Severe malaria is caused by both the aggregation of red blood cells infected by the parasite into rosettes and via cytoadherence, the attachment of red blood cells to the cells of the host, lining the blood vessels. Rosette formation and cytoadherence both prevent proper transport of oxygen by the red blood cells around the capilaries of the brain and causes blockages, damaging the brain, and this is often fatal. This project will identify the simplest fragments, from a novel semi-synthetic library of negatively charged carbohydrates, that are able to disrupt rosetting and cytoadherence while minimising/eliminating any potential side-effects. This will provide information concerning the minimum structures required, allowing cheap, chemical synthesis of the molecules to be undertaken. This project will ultimatley lead to the development of new pharmaceutical agents, which are urgently needed, as resistance emerges to the drugs being administered currently.</gtr:abstractText><gtr:technicalSummary>Malaria, caused by Plasmodium species, affects one third of the world?s population with over 300 million infections resulting in 2 million deaths annually. Severe malaria, caused by P. falciparum, is the most serious complication of the disease resulting in widespread suffering and economic damage, especially in developing nations. Severe malaria severity correlates with the extent of venule occlusion (by rosetting, auto-aglutination and cytoadherance) resulting in hypoxia and coma. Cell-cell adhesions are facilitated by interactions between parasite expressed proteins and host carbohydrates (hyaluronic acid, chondroitin sulfate, heparan sulfate) and proteins (CD-36, E-selectin, PECAM-1, ICAM-1, VCAM-1 and thrombospondin) while the rosetting process is mediated principally by the parasite expressed protein, P. falciparum erythrocyte membrane protein-1 (PfEMP-1) through attachment to host cell-surface carbohydrates. It has been shown that both naturally occuring and chemically modified carbohydrates are capable of disrupting malaria rosettes and/or cytoadherance, but the structural details of these interactions, and the carbohydrates themselves, remain poorly defined. This project will create an arsenal of semi-synthetic, structurally diverse polysaccharides which will faciitate the generation of a series of size-defined, structurally diverse oligosaccharides from which the simplest structures (i.e. smallest and least charged) capable of inhibiting rosetting and cytoadherence will be selected, purified and their detailed structures defined by a combination of recently developed sequencing techniques (e.g. ES-MS and NMR). As a precaution, successful inhibitors will also be screened for potential side-effects, including the formation of immunogenic platelet factor-IV complexes and activities with the blood clotting cascade (anti-factor Xa, antithrombin and factor II) activities, which can be highly attenuated (down to 0.5 %) with simple chemical modifications. The structural information will not only provide detailed data concerning the nature of the interacting species, leading to improved mechanistic understanding, but will also provide the structurally simplest targets for future chemical synthesis, the first step to producing new pharmaceutical agents.</gtr:technicalSummary><gtr:fund><gtr:end>2012-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>464470</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cytoadherence and inhibition with polysaccharides</gtr:description><gtr:id>74336BD6-EDE5-4DF2-889C-2F20E3C5637B</gtr:id><gtr:impact>paper in preparation:

Reversal and Inhibition of P.falciparum cytoadherence by chemically modified polysaccharide analogues of glycosaminoglycans.M. Khairul, M.A.Skidmore, A.C.Craig and E.A.Yates (in preparation)</gtr:impact><gtr:partnerContribution>Provided assay for cytoadherence</gtr:partnerContribution><gtr:piContribution>Provide polysaccharides to inhibit and reverse cytoadherence</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>San Raffaele Hospital</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Virology</gtr:department><gtr:description>inhibitors of viral attachment</gtr:description><gtr:id>9F220DD0-07E6-4A45-B6C1-57D988FFCE53</gtr:id><gtr:impact>Inhibition of influenza H1N1 viral entry into cells. A. Ruzentska, M.A.Skidmore, E.A.Yates and E.Vicenzi</gtr:impact><gtr:partnerContribution>provided assays of viral entry into cells</gtr:partnerContribution><gtr:piContribution>Provided inhibitors of viral attachment and invasion</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Keele University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences Keele</gtr:department><gtr:description>Collaboration in infectivity studies with University of Keele</gtr:description><gtr:id>A0626C9E-758C-4172-B7A4-D93CEF45190B</gtr:id><gtr:impact>Publication in preparation</gtr:impact><gtr:partnerContribution>Assays of invasion</gtr:partnerContribution><gtr:piContribution>Provision of sulfated inhibitors of parasite invasion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>RSC invited talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3C9D3913-3A87-448E-8273-E68E29F7C739</gtr:id><gtr:impact>Invited Talk. Royal Society of Chemistry Autumn Meeting of the Carbohydrate Group, Liverpool, 13th-17th september 2011. (www.rsc.org/ConferncesAndEvents)

New experimental design formed following discussions, which has been conducted by undergraduate research students.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>004664F3-4A43-4073-A92E-3A59FB239F56</gtr:id><gtr:impact>6th International Conference on proteoglycans, Aix-les-Bains, France. &amp;quot;GAG analogues disrupt P.falciparum malaria&amp;quot; 13th-17th September 2009. (http://pg2009-fr/.Aix-les-Bains)

new collaborative links</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to visiting medical students from Saudi Arabia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9FE3E790-84BE-46CB-A46A-A3648A3D0096</gtr:id><gtr:impact>Medical Students from Saudi Arabia were given a talk about potential treatments for malaria based on carbohydrates.

Several expressed interest in studying in UK</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk to University of New South Wales</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AFD548B9-29EA-4DDF-8532-4BAC814E2FD1</gtr:id><gtr:impact>Audience questions answered and potential collaborative links formed

University of New South Wales, Australia (2010) &amp;quot;GAGs, Chemically Modified derivatives and Semi-synthetic analogues: new technologies paving the way towards glycotherapies&amp;quot;. Interest from potential new collaborators.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ICOPA Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>645CF90B-C26F-4709-A809-C20B6CD6F457</gtr:id><gtr:impact>100 + audience with questions and enquiries


Useful exchange of know-how and materials.

ICOPA XII, Melbourne Australia, 15/08/12-20/08/10 (www.icopaxii.org)</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>invited talk keele</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3D20BB45-5FB8-4797-AE36-5BCD7F52AE95</gtr:id><gtr:impact>NEMO EU-Marie Curie Actions, ITN Network-, University of Keele, 13-17/09/12. &amp;quot;Prebiotics and probiotics in medicine, veterinary sciences and aquaculture: the future&amp;quot;
(www.keele-conferencemanagement.com/nemo.2012)

Collaboration with Brazilian research group initiated</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.keele-conferencemanagement.com/nemo.2012</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>8E9A73CE-23A0-4B01-BF08-531985690F4C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>a family of sulfated polysaccharides with several interesting biological activities in addition to those of the grant also developed several assays</gtr:description><gtr:id>58CA2CBB-2082-4C1B-9784-9B9B17693228</gtr:id><gtr:impact>assays measuring inhibition of viral attachment are underway</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>sulfated polysaccharide library</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8E82FBE-AC9A-46B2-9465-23ED4E84EEC9"><gtr:id>E8E82FBE-AC9A-46B2-9465-23ED4E84EEC9</gtr:id><gtr:title>Inhibition of influenza H5N1 invasion by modified heparin derivatives</gtr:title><gtr:parentPublicationTitle>Med. Chem. Commun.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35e3409b071e279a8053a50dee0790ce"><gtr:id>35e3409b071e279a8053a50dee0790ce</gtr:id><gtr:otherNames>Skidmore M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700852</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>